Loading company…
Riskpilot
← Back to search
Sign in
Get full access
SVANEN APOTEK AS
AS
Active
Org 930943053
Bruene 1, 3724 Skien
Retail sale of pharmaceutical products · NACE 4773
Est. 2023
7 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 24,8M
+62% vs 2023
EBITDA margin
3.0%
-41% vs 2023
Equity ratio
10.5%
Financial strength
Net profit 2024
NOK 594K
-40% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
1M
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 24,8M
+62%
EBITDA
NOK 752K
-41%
Net profit
NOK 594K
-40%
Total assets
NOK 6M
-18%
Equity
NOK 633K
+1528%
Employees
7
—
Company information
Legal name
SVANEN APOTEK AS
Org number
930943053
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
6. mars 2023
Share capital
NOK 30 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene. Daglig leder alene.
Company purpose
Drive apotek og farmasøytiske vare, samt det som naturlig står i forbindelse med dette.
Contact
Address
Bruene 1, 3724 Skien
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Skien
All Norway companies
Revenue
NOK millions
0M
7M
14M
22M
29M
15M
2023
25M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
15 268
24 800
Staff expenses
−2 939
−4 332
EBITDA
1 264
752
Depreciation & amort.
−2
−5
EBIT
1 263
748
Net financials
−0
17
Profit before tax
1 262
765
Tax
278
170
Net profit
984
594
Balance sheet
NOK thousands
Item
2023
2024
Total assets
7 332
6 021
Equity
39
633
Long-term debt
1
4
Short-term debt
7 292
5 384
Total debt
7 293
5 388
Financial ratios
5-year trend
EBITDA margin
3.0%
This company
15.8%
Market median
-81% vs market
2023
2024
Equity ratio
10.5%
This company
38.2%
Market median
-73% vs market
2023
2024
Return on equity
93.9%
This company
18.4%
Market median
+410% vs market
2023
2024
Net profit margin
2.4%
This company
8.1%
Market median
-70% vs market
2023
2024
Asset turnover
4.12×
This company
1.12×
Market median
+268% vs market
2023
2024
Debt / equity
8.51×
This company
0.62×
Market median
-1273% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-02-19 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
HM
Hafiz Muhammad Umer
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
MF
Muhammad Furqan
Chairman
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of SVANEN APOTEK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Hafiz Muhammad Umer
Chief Executive Officer
0 companies
Muhammad Furqan
Chairman
0 companies